what is compound tirzepatide Compounded GLP-1/GIP Program Ivím Health | Compounded Tirzepatide

References Marso, S

Get the realistic before and after timeline inside

Heres what early studies have shown: Pancreatitis: Reported in about 0.4% Gallbladder problems: Seen in about 1.1% , with no cases in the placebo group Heart rhythm changes: Reported more often with retatrutide ( about 6% vs 3% with placebo ) Liver enzyme increases: Rare (around 1% ), with overall liver health markers staying stable While these serious side effects were uncommon, theyre still important to keep in mind

Enhancing angiogenic activity and microvascular support

This makes it a popular option during fat-loss phases, conditioning blocks, and endurance-focused training

& Schmidt, W